Keywords

ABSSSI, acute bacterial skin and skin structure infections, dalbavancin, daptomycin, lipoglycopeptides, oritavancin, telavancin, vancomycin

Authors

1. Bell, Allison M. PharmD
2. King, S. Travis PharmD
3. Barber, Katie E. PharmD
4. Adcock, Kim G. PharmD
5. Wagner, Jamie L. PharmD
6. Stover, Kayla R. PharmD

Abstract

Abstract: Acute bacterial skin and skin structure infections (ABSSSI) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSI are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, two new lipoglycopeptides, in the context of the other I.V. available standard therapy options.